NEW YORK (TheStreet) - For the last 12 months, these 10 stocks from diverse industries had the highest return on assets of 23% to 80%, return on equity ranging from 28% to 252% and return on capital employed ranging from 31% to 71%. These stocks have upside potential in the range of 23% to 61%, based on average estimates of analysts polled by Bloomberg.
Below, we've listed them in ascending order of upside potential.
10. Momenta Pharmaceuticals (MNTA) is a biotechnology company with a market cap exceeding $891 million. It specializes in the analysis of complex mixture drugs and the development of novel drugs.
The company's return on assets in the last 12 months was 79.80%, while total asset turnover ratio was 1.14. Return on equity and return on capital employed in the last 12 months stood at a healthy 85.32% and 86.35%, respectively. The stock is trading at 4.01 times earnings, vs. the industry average P/E of 22.24, according to data compiled by Bloomberg. For the latest third quarter, Momenta reported revenue at $87.9 million, up 69.3%. Net income was $60.3 million, or $1.18 per diluted share, compared with $32.1 million, or 70 cents per share, for the same period last year. Momenta recently announced a global collaboration with Baxter International to develop and commercialize follow-on biologic products, or biosimilars, which replicate existing, branded biologics used in the treatment of a variety of diseases including cancer, autoimmune disorders and other chronic conditions. The company has announced an agreement to acquire the Sialic Switch assets of Virdante Pharmaceuticals for $51.5 million. Of the 10 analysts covering the stock, seven recommend a buy and three rate a hold. Analysts polled by Bloomberg foresee the stock gaining an average 23.1% to $21.71 in the upcoming 12 months.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV